Trinity Biotech | TRIB - Operating Profit

Stock Price
0.72
Daily Change
-0.06 -8.10%
Monthly
-6.49%
Yearly
-10.63%
Q1 Forecast
0.79

Trinity Biotech reported $-509K in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Bayer EUR -543M 556M Sep/2025
Bio-Rad Laboratories USD 77.1M 53.4M Jun/2025
EDAP TMS EUR -5.77M 228K Jun/2025
J&J USD 5.59B 1.81B Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Siemens EUR 2.57B 189M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Tosoh JPY 25.15B 3.51B Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025
Veracyte USD 23.11M 8.8M Sep/2025